Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen ...

Biogen Inc. is fending off a lawsuit in the Delaware Chancery Court over its recent offer to buy out Sage Therapeutics, its ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

Biogen’s effort to buy Sage against the board’s wishes and a long-time effort by investor Alcorn to scuttle Aurion’s IPO ...

Last Friday, Biogen offered to buy Sage Therapeutics, its marketing partner ... "We are doubling down in Alzheimer's," the CEO said, noting that news is expected this year on an FDA filing for ...

Last Friday, Biogen offered to buy Sage Therapeutics, its marketing partner on a drug to ... "We are doubling down in Alzheimer's," the CEO said, noting that news is expected this year on an FDA ...

Late last week, Biogen made an unsolicited offer to buy one of its partners, brain drug developer Sage Therapeutics ... top executive Barry Greene, Biogen CEO Christopher Viehbacher wrote that ...

SAN FRANCISCO — Biogen would like to make additional biotech acquisitions in 2025 beyond Friday’s offer to buy its financially troubled partner Sage Therapeutics, chief executive Chris ...